Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DUPILUMAB
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- Early-onset Dupilumab Effects in CRSwNP
- Dupilumab De-escalation in Pediatric Atopic Dermatitis
- A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)
- Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.
- The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction
- Dupilumab in Chinese Adult Participants With CRSwNP
- Dupilumab in the Treatment of Pediatric Alopecia Areata
- Molecular Signatures of Cutaneous Dupilumab Response
- A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis
- A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clin
- Dupilumab Effects Against Aeroallergen Challenge
- Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
- Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China
- Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders: a Single-Site Pilot Study
- Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis
- Dupilumab Skin Barrier Function and Lipidomics Study in Atopic Dermatitis in China
- Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab
- A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
- Dupilumab In Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-seVere Eczema tRial
- Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
- Regeneron AA Multicenter (Dupilumab)
- Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)
- Biologics and Blistering
- A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) or Chronic Inducible Cold Urticaria (CICU) (LIBERTY-CSU/CINDU CUPIDKids)
- Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
- IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
- A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
- Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
- Dupixent and Narrowband UVB for Atopic Dermatitis
- Ethnic Differences in Mechanisms of Action of Dupilumab
- Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
- Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis
- Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
- Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
- Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
- Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
- Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)
- Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
- Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma
- Mechanisms of Dupilumab in AERD
- Dupilumab_Metastatic NSCLC
- EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
- Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children
- Dupilumab in the Treatment of Keloids
- Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients
- Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood
- NMF-CsA-Dupi Trial
- Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
- Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis
- A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis
- Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
- Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis
- Dupilumab in Allergic Fungal Rhinosinusitis (AFRS)
- Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
- Dupilumab in Japanese Patients With Atopic Dermatitis
- Dupilumab in CRSsNP (Liberty CRSsNP ORION)
- Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema
- Dupilumab for Prevention of Recurrence of CRSwNP After ESS
- An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
- Dupilumab in Severe Chronic Hand Eczema
- Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction
- Dupilumab Asthma Sleep Study
- Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation
- Dupilumab Skin Barrier Function Study in Atopic Dermatitis
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
- Effect of Dupilumab on Aspirin Intolerance
- Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)
- The Effect of Dupilumab on Lung Function and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma
- Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
- Viral Infection in Asthma (VIA) Study
- Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
- Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
- Apremilast 30 mg BID Combined With Dupilumab
- Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
- Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
- A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
- A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)
- Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma
- Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable
- Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab
- Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy
- SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
- Dupilumab Impact on Skin Resident Memory T Cells
- The Effects of Dupilumab on Allergic Contact Dermatitis
- Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation
- Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
- Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
- Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids
- Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
- Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma
- Cholinergic Urticaria - Efficacy of Dupilumab
- Dupilumab in Chronic Spontaneous Urticaria
- A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
- Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
- Investigating Dupilumab's Effect in Asthma by Genotype
- Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
- Clinical Study Using Biologics to Improve Multi OIT Outcomes
- Dupilumab in Eosinophilic Gastritis
- Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
- The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
- Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
- Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
- Dupilumab for Aspirin-exacerbated Respiratory Disease
- Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
- Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
- Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
- Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants
- Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
- Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)
- Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
- Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
- Study of REGN3500 and Dupilumab in Patients With Asthma
- Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
- Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
- Evaluation of Dupilumab in Children With Uncontrolled Asthma
- A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps
- Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps
- A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable
- Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
- Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
- Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
- Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
- Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
- A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
- A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
- Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)
- Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)
- Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)
- Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
- Open-label Study of Dupilumab in Patients With Atopic Dermatitis
- An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis
- Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
- Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)
- Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
- Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
- Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Clinical trials list
click for details